[
  {
    "ts": null,
    "headline": "Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, Goldman Sachs raised the firm’s price target on Bristol-Myers Squibb Company (NYSE:BMY) to $57 from $51 and kept a Neutral rating on the shares. Bristol-Myers Squibb Company (NYSE:BMY) presents a measured balance between risk and […]",
    "url": "https://finnhub.io/api/news?id=6e5f14b4fb27937622324b04c33a49f1782c131b5aa2ed07fdae4962a53d7cbf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767135354,
      "headline": "Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating",
      "id": 137950466,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 15, Goldman Sachs raised the firm’s price target on Bristol-Myers Squibb Company (NYSE:BMY) to $57 from $51 and kept a Neutral rating on the shares. Bristol-Myers Squibb Company (NYSE:BMY) presents a measured balance between risk and […]",
      "url": "https://finnhub.io/api/news?id=6e5f14b4fb27937622324b04c33a49f1782c131b5aa2ed07fdae4962a53d7cbf"
    }
  },
  {
    "ts": null,
    "headline": "BMY vs AMGN: Which Biotech Stock Is More Resilient Now?",
    "summary": "AMGN edges out its rival with stronger growth estimates, a broad portfolio boost from Horizon, and momentum from key drugs like Repatha and Tezspire.",
    "url": "https://finnhub.io/api/news?id=fb26d8e8074750d7c719c4a173a8088ffa55da5a5f4fd470ed52b49edf6cbe52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767118920,
      "headline": "BMY vs AMGN: Which Biotech Stock Is More Resilient Now?",
      "id": 137943948,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "AMGN edges out its rival with stronger growth estimates, a broad portfolio boost from Horizon, and momentum from key drugs like Repatha and Tezspire.",
      "url": "https://finnhub.io/api/news?id=fb26d8e8074750d7c719c4a173a8088ffa55da5a5f4fd470ed52b49edf6cbe52"
    }
  },
  {
    "ts": null,
    "headline": "Is Bristol Myers Squibb a Buy, Sell, or Hold in 2026?",
    "summary": "The stock has been on the rebound for several months, but can it keep the momentum going?",
    "url": "https://finnhub.io/api/news?id=2b5081e335c94f2ada8442331949024d9c2fd388ab17c3df9a520fe8fee80351",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767110700,
      "headline": "Is Bristol Myers Squibb a Buy, Sell, or Hold in 2026?",
      "id": 137941976,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The stock has been on the rebound for several months, but can it keep the momentum going?",
      "url": "https://finnhub.io/api/news?id=2b5081e335c94f2ada8442331949024d9c2fd388ab17c3df9a520fe8fee80351"
    }
  },
  {
    "ts": null,
    "headline": "How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks",
    "summary": "The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",
    "url": "https://finnhub.io/api/news?id=3d4e3d2ecef5236aaff9433e4ae4f05ebc60cb276a86a7c987d57230bbbeea1f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767105602,
      "headline": "How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks",
      "id": 137941988,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",
      "url": "https://finnhub.io/api/news?id=3d4e3d2ecef5236aaff9433e4ae4f05ebc60cb276a86a7c987d57230bbbeea1f"
    }
  },
  {
    "ts": null,
    "headline": "Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever",
    "summary": "Investors seeking reliable dividends will find that this trio of healthcare stocks offers an exciting combination of safety, growth, and income.",
    "url": "https://finnhub.io/api/news?id=f47296a46b61bef010599896d15e6917727acebf41489a92390b84fd55918211",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767105300,
      "headline": "Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever",
      "id": 137940275,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Investors seeking reliable dividends will find that this trio of healthcare stocks offers an exciting combination of safety, growth, and income.",
      "url": "https://finnhub.io/api/news?id=f47296a46b61bef010599896d15e6917727acebf41489a92390b84fd55918211"
    }
  },
  {
    "ts": null,
    "headline": "What Does Wall Street Think About Bristol-Myers Squibb Company (BMY)?",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best affordable healthcare stocks to buy now. On December 22, Bristol-Myers Squibb Company (NYSE:BMY) received a Buy rating from Guggenheim with a price target of $62.00. In a separate development, Bristol-Myers Squibb Company (NYSE:BMY) announced on December 19 an agreement with the United States government for the provision of […]",
    "url": "https://finnhub.io/api/news?id=74ca64804b67ac2b95175969b866a853786174b2532a4f9007bc08be402e28e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767070789,
      "headline": "What Does Wall Street Think About Bristol-Myers Squibb Company (BMY)?",
      "id": 137940458,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best affordable healthcare stocks to buy now. On December 22, Bristol-Myers Squibb Company (NYSE:BMY) received a Buy rating from Guggenheim with a price target of $62.00. In a separate development, Bristol-Myers Squibb Company (NYSE:BMY) announced on December 19 an agreement with the United States government for the provision of […]",
      "url": "https://finnhub.io/api/news?id=74ca64804b67ac2b95175969b866a853786174b2532a4f9007bc08be402e28e6"
    }
  }
]